In particular, one CNV includes the gene for PPARG, a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors, which resulted highly expressed in bladder cancer and could be an attractive molecular target for the development of novel treatment strategies for this type of tumor [5]. Here, PPARG is linked to neoplasm.